US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 4.2807
  • -0.7993-15.73%
Close Nov 15 16:00 ET
  • 4.2819
  • +0.0012+0.03%
Post 20:01 ET
3.07MMarket Cap-558P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
53.26%-7.28M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
15.01%-2.26M
Net income from continuing operations
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
Operating gains losses
936.52%12.26K
1,110.99%9.66K
5,717.24%1.63K
-65.34%-1.04K
-27.83%2.02K
-90.99%1.18K
-165.50%-955
96.01%-29
-105.65%-629
121.55%2.8K
Depreciation and amortization
1.43%604.52K
0.59%151.86K
1.02%150.69K
3.56%152.61K
0.58%149.36K
16.45%596K
-2.00%150.97K
-2.71%149.16K
-1.74%147.36K
172.80%148.51K
Other non cash items
-55.67%-1.25K
105.11%21
-1,069.23%-252
-61.41%-481
-348.33%-538
-100.06%-803
-100.03%-411
--26
---298
99.31%-120
Change In working capital
34.73%-369.34K
352.62%665.61K
-395.36%-418.82K
16.90%-709.77K
-77.16%93.65K
81.59%-565.82K
80.85%-263.48K
106.39%141.8K
-340.14%-854.16K
143.64%410.02K
-Change in receivables
57.82%-92.44K
-29.85%-145.16K
286.33%165.19K
-126.09%-207.02K
29.77%94.55K
-447.76%-219.15K
-539.79%-111.79K
-337.79%-88.65K
-14,451.57%-91.56K
2,592.58%72.86K
-Change in inventory
-88.29%66.22K
-399.09%-92.78K
-258.38%-449.11K
31.98%217.78K
187.94%390.33K
128.23%565.56K
98.26%-18.59K
165.71%283.58K
132.89%165.02K
--135.56K
-Change in prepaid assets
-93.22%20.28K
174.35%540.94K
-28.42%94.29K
-90.95%-897.96K
-35.76%283.02K
56.92%299.19K
-61.66%197.17K
111.25%131.73K
-320.82%-470.27K
-30.56%440.56K
-Change in payables and accrued expense
105.61%45.28K
312.82%470.73K
-36.45%-104.34K
169.04%241.38K
-253.19%-562.48K
0.62%-806.53K
64.12%-221.19K
84.44%-76.47K
-145.66%-349.61K
66.06%-159.26K
-Change in other current assets
-10.88%4.91K
--0
--0
--1.79K
-43.38%3.12K
108.96%5.51K
--0
--0
--0
-8.67%5.51K
-Change in other current liabilities
6.83%-397.42K
0.88%-108.12K
11.24%-96.19K
12.76%-94.4K
2.17%-98.71K
-24.78%-426.58K
0.13%-109.09K
-0.81%-108.38K
---108.21K
---100.9K
-Change in other working capital
-200.00%-16.17K
--0
---28.66K
5,984.08%28.66K
-203.00%-16.17K
414.49%16.17K
--0
--0
--471
--15.7K
Cash from discontinued investing activities
Operating cash flow
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
53.26%-7.28M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
15.01%-2.26M
Investing cash flow
Cash flow from continuing investing activities
98.60%-9.29K
0
100.00%-2
98.14%-9.29K
0
1.66%-661.8K
95.37%-33.61K
-3,508.16%-128.2K
-263.39%-500K
0
Net PPE purchase and sale
94.26%-9.29K
--0
100.00%-2
----
----
-313.74%-161.8K
---33.61K
-3,508.16%-128.2K
----
----
Net business purchase and sale
--0
--0
--0
----
----
-139.36%-500K
--0
--0
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
98.60%-9.29K
--0
100.00%-2
98.14%-9.29K
--0
1.66%-661.8K
95.37%-33.61K
-3,508.16%-128.2K
-263.39%-500K
--0
Financing cash flow
Cash flow from continuing financing activities
-56.42%4.65M
176
0
-12.44%4.65M
0
-29.13%10.68M
0
-117.31%-63.7K
735.69%5.32M
-50.12%5.43M
Net common stock issuance
-56.42%4.65M
100.15%1
--0
-1.90%4.65M
--0
-37.71%10.68M
-100.01%-646
---63.7K
2,695,346.59%4.74M
-50.00%6M
Proceeds from stock option exercised by employees
-72.91%175
----
----
----
----
--646
----
----
----
----
Net other financing activities
----
----
----
----
----
----
----
----
----
48.77%-571.26K
Cash from discontinued financing activities
Financing cash flow
-56.42%4.65M
--176
--0
-12.44%4.65M
--0
-29.13%10.68M
--0
-117.31%-63.7K
735.69%5.32M
-50.12%5.43M
Net cash flow
Beginning cash position
44.29%8.91M
-20.86%7.6M
-16.74%9.53M
-27.94%6.74M
44.29%8.91M
-16.11%6.18M
62.83%9.6M
1.53%11.45M
-39.06%9.35M
-16.11%6.18M
Current changes in cash
-185.57%-2.34M
-48.80%-1.03M
-4.64%-1.93M
33.04%2.8M
-168.51%-2.17M
330.61%2.74M
-348.26%-691.54K
65.65%-1.85M
151.73%2.1M
-60.23%3.17M
End cash Position
-26.27%6.57M
-26.27%6.57M
-20.86%7.6M
-16.74%9.53M
-27.94%6.74M
44.29%8.91M
44.29%8.91M
62.83%9.6M
1.53%11.45M
-39.06%9.35M
Free cash flow
6.04%-7M
-48.82%-1.03M
-8.38%-1.93M
31.54%-1.86M
3.61%-2.17M
52.35%-7.45M
82.91%-691.54K
66.65%-1.78M
23.99%-2.71M
15.01%-2.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.08%-6.99M-56.42%-1.03M-16.76%-1.93M31.88%-1.85M3.61%-2.17M53.26%-7.28M83.74%-657.93K69.03%-1.66M23.22%-2.71M15.01%-2.26M
Net income from continuing operations 3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M
Operating gains losses 936.52%12.26K1,110.99%9.66K5,717.24%1.63K-65.34%-1.04K-27.83%2.02K-90.99%1.18K-165.50%-95596.01%-29-105.65%-629121.55%2.8K
Depreciation and amortization 1.43%604.52K0.59%151.86K1.02%150.69K3.56%152.61K0.58%149.36K16.45%596K-2.00%150.97K-2.71%149.16K-1.74%147.36K172.80%148.51K
Other non cash items -55.67%-1.25K105.11%21-1,069.23%-252-61.41%-481-348.33%-538-100.06%-803-100.03%-411--26---29899.31%-120
Change In working capital 34.73%-369.34K352.62%665.61K-395.36%-418.82K16.90%-709.77K-77.16%93.65K81.59%-565.82K80.85%-263.48K106.39%141.8K-340.14%-854.16K143.64%410.02K
-Change in receivables 57.82%-92.44K-29.85%-145.16K286.33%165.19K-126.09%-207.02K29.77%94.55K-447.76%-219.15K-539.79%-111.79K-337.79%-88.65K-14,451.57%-91.56K2,592.58%72.86K
-Change in inventory -88.29%66.22K-399.09%-92.78K-258.38%-449.11K31.98%217.78K187.94%390.33K128.23%565.56K98.26%-18.59K165.71%283.58K132.89%165.02K--135.56K
-Change in prepaid assets -93.22%20.28K174.35%540.94K-28.42%94.29K-90.95%-897.96K-35.76%283.02K56.92%299.19K-61.66%197.17K111.25%131.73K-320.82%-470.27K-30.56%440.56K
-Change in payables and accrued expense 105.61%45.28K312.82%470.73K-36.45%-104.34K169.04%241.38K-253.19%-562.48K0.62%-806.53K64.12%-221.19K84.44%-76.47K-145.66%-349.61K66.06%-159.26K
-Change in other current assets -10.88%4.91K--0--0--1.79K-43.38%3.12K108.96%5.51K--0--0--0-8.67%5.51K
-Change in other current liabilities 6.83%-397.42K0.88%-108.12K11.24%-96.19K12.76%-94.4K2.17%-98.71K-24.78%-426.58K0.13%-109.09K-0.81%-108.38K---108.21K---100.9K
-Change in other working capital -200.00%-16.17K--0---28.66K5,984.08%28.66K-203.00%-16.17K414.49%16.17K--0--0--471--15.7K
Cash from discontinued investing activities
Operating cash flow 4.08%-6.99M-56.42%-1.03M-16.76%-1.93M31.88%-1.85M3.61%-2.17M53.26%-7.28M83.74%-657.93K69.03%-1.66M23.22%-2.71M15.01%-2.26M
Investing cash flow
Cash flow from continuing investing activities 98.60%-9.29K0100.00%-298.14%-9.29K01.66%-661.8K95.37%-33.61K-3,508.16%-128.2K-263.39%-500K0
Net PPE purchase and sale 94.26%-9.29K--0100.00%-2---------313.74%-161.8K---33.61K-3,508.16%-128.2K--------
Net business purchase and sale --0--0--0---------139.36%-500K--0--0--------
Net investment purchase and sale --0--0--0--0--0--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 98.60%-9.29K--0100.00%-298.14%-9.29K--01.66%-661.8K95.37%-33.61K-3,508.16%-128.2K-263.39%-500K--0
Financing cash flow
Cash flow from continuing financing activities -56.42%4.65M1760-12.44%4.65M0-29.13%10.68M0-117.31%-63.7K735.69%5.32M-50.12%5.43M
Net common stock issuance -56.42%4.65M100.15%1--0-1.90%4.65M--0-37.71%10.68M-100.01%-646---63.7K2,695,346.59%4.74M-50.00%6M
Proceeds from stock option exercised by employees -72.91%175------------------646----------------
Net other financing activities ------------------------------------48.77%-571.26K
Cash from discontinued financing activities
Financing cash flow -56.42%4.65M--176--0-12.44%4.65M--0-29.13%10.68M--0-117.31%-63.7K735.69%5.32M-50.12%5.43M
Net cash flow
Beginning cash position 44.29%8.91M-20.86%7.6M-16.74%9.53M-27.94%6.74M44.29%8.91M-16.11%6.18M62.83%9.6M1.53%11.45M-39.06%9.35M-16.11%6.18M
Current changes in cash -185.57%-2.34M-48.80%-1.03M-4.64%-1.93M33.04%2.8M-168.51%-2.17M330.61%2.74M-348.26%-691.54K65.65%-1.85M151.73%2.1M-60.23%3.17M
End cash Position -26.27%6.57M-26.27%6.57M-20.86%7.6M-16.74%9.53M-27.94%6.74M44.29%8.91M44.29%8.91M62.83%9.6M1.53%11.45M-39.06%9.35M
Free cash flow 6.04%-7M-48.82%-1.03M-8.38%-1.93M31.54%-1.86M3.61%-2.17M52.35%-7.45M82.91%-691.54K66.65%-1.78M23.99%-2.71M15.01%-2.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data